Why this large cap stock could be a star performer even amid a potential May sell-off

The month of May is typically a bad period for shares but Nufarm Limited (ASX: NUF) could find fortune next month as investors catch on to the upside from its omega-3 opportunity.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We are heading into the stock killin' season of May – a month that has traditionally marked the start of a weak, if not dismal, period for global equities.

Hang on Fools! The backdrop of rising volatility and increased trepidation towards the upcoming bank profit reporting season could make next month a stomach-churning event compared to this time last year when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) crashed by nearly 4%.

However, there is one stock that looks well placed to outperform the broader market next month regardless of whether the "sell in May, go away" market adage comes to pass.

I am referring to Nufarm Limited (ASX: NUF) as the seed and crop protection products supplier gears up for its Investor Day on May 10.

Analysts are coming to the view that this event could be a catalyst for Nufarm's share price, particularly around its new Omega-3 enriched seed product.

Calling this product line a "game changer" is probably too strong a term but I don't think the market has fully appreciated the upside potential from this new offering.

I believe that omega-3 is to Nufarm as the A2 milk protein is to A2 Milk Company Ltd (ASX: A2M) – except there is more science backing the health benefits of omega-3 than A2 milk protein but that's a story for another time.

Supply of omega-3 has come from fish and Morgan Stanley believes there is a big global shortage of fish oil emerging.

"Demand for fish and therefore fish oil remains underpinned by a growing population with increasing health consciousness. We forecast ~4% growth p.a. in fish oil demand over the next 10 years," said Morgan Stanley.

"Against a backdrop of stagnant supply, we see a global deficit of ~440kt emerging over this time frame (~50% of current supply)."

This is why the broker is bullish about the medium to longer-term outlook for Nufarm as its land-based solution to the looming omega-3 deficit is not only sustainable and scalable, but Nufarm's first mover advantage could see it become a major global supplier of omega-3 over the coming years.

Morgan Stanley has an "overweight" recommendation on the stock with a price target of $11.75 a share.

That leaves a decent upside to the stock even as it gained another 0.8% to $9.12 this morning.

What's more, Nufarm is a laggard with the stock wallowing 7% in the red over the past 12-months when its peers Incitec Pivot Ltd (ASX: IPL) and Orica Ltd (ASX: ORI) are at breakeven and 5.4% ahead, respectively.

This could be about to change in May.

Looking for other stocks that are well placed to outperform? The experts at the Motley Fool are bullish about one sector in particular as they believe this sector will make a big impact on our market in 2018 and beyond.

Follow the link below to get your free report on this sector and to find out what stocks are best leveraged to this emerging thematic.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »